Company intelligence / Profile preview

BioRox

Ownership: Private
Development stage: Other

Overview

BioRox provides comprehensive CMC consulting and operational support for biologics and advanced biological therapies—including gene and cell therapies—across all stages from early product design to commercialization. The company has contributed to successful regulatory filings, process development, GMP manufacturing strategies, facility design, CDMO selection/management, due diligence assessments for investors/acquisitions, and more[1].

Therapeutic areas: Other
Modalities: Gene therapyCell therapyBiologic
Industry: Consulting

Partnerships

Multiple client engagements in biopharma sector (specific partners not disclosed)[1]

Beyond the preview

Go deeper on BioRox.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioRox.

Explore the full profile